Moderator: Jongwook PARK (Korea)
Time | Program | Chair / Speaker |
---|---|---|
10:30-11:30 | Poster Session | |
11:30-12:30 | Lunch | |
12:30-12:50 | Welcome Remarks | Sung Kyu HONG (President, KPS) |
Ji Youl LEE (President, APSU) | ||
Jun Hyuk HONG (President, KUA) | ||
12:50-14:00 | Session I: Urothelial Cancer I (NMIBC) | Jun Sung KOH (Korea) |
Masatoshi ETO (Japan) | ||
12:50-13:05 | Management of recurrent low-grade intermediate-risk bladder cancer despite intravesical chemotherapy or BCG | Se Young CHOI (Korea) |
13:05-13:20 | Is re-TURB really necessary for all high-grade NMIBC? | Sungchan PARK (Korea) |
13:20-13:50 | Emerging therapies in non-muscle invasive bladder cancer | Seth LERNER (USA) |
13:50-14:00 | Case Discussion: Low grade, recurrent, intermediate-risk NMIBC refractory to BCG |
Moderator: Taek Sang KIM (Korea) |
Kyung Jin JUNG (Korea) | ||
Kwang Hyun KIM (Korea) | ||
Lukman HAKIM (Indonesia) | ||
14:00-14:20 | Satellite Symposium sponsored by Janssen | Sung Kyu HONG (Korea) |
The role of Erleada in mHSPC: optimal start, saving other options for the future | Phil Hyun SONG (Korea) | |
14:20-14:40 | Coffee Break / Visit Exhibits | |
14:40-16:40 | Session II: Prostate Cancer I | Jae Il CHUNG (Korea) |
Jae Young JOUNG (Korea) | ||
14:40-15:10 | The evolution of radical prostatectomy in the management of prostate cancer | James EASTHAM (USA) |
15:10-15:20 | Q & A | |
15:20-15:50 | Sequencing systemic therapies post ARPI in mHRPC | Deaglan McHugh (USA) |
15:50-16:00 | Q & A | |
16:00-16:30 | Highlights of APCCC 2024 | Silke GILLESSEN (Switzerland) |
16:30-16:40 | Q & A | |
Panels discussion | Gyeong Eun MIN (Korea) | |
Won Tae KIM (Korea) | ||
Ki Soo LEE (Korea) | ||
Jongsoo LEE (Korea) | ||
17:00 | Welcome Dinner |
Moderator: Jongwook PARK (Korea)
Time | Program | Chair / Speaker |
---|---|---|
09:00-10:10 | Session III: Prostate Cancer II (Locally advanced disease) | Ji Youl LEE (Korea) |
Hung-Jen Wang (Taiwan) | ||
09:00-09:15 | How to best manage patients with locally advanced prostate cancer?; Surgery vs Radiation therapy |
Hongzoo PARK (Korea) |
09:15-09:30 | How to best manage patients with locally advanced prostate cancer?; Adjuvant vs Early salvage Radiation therapy |
Hakmin LEE (Korea) |
09:30-10:00 | Is it all or is it none? Role of pelvic lymph node dissection at the time of radical prostatectomy | James EASTHAM (USA) |
10:00-10:10 | Case Discussion: Locally advanced prostate cancer |
Moderator: Hyung Joon KIM (Korea) |
Jae Duck CHOI (Korea) | ||
Yu Seob SHIN (Korea) | ||
Sang Hun SONG (Korea) | ||
10:10-10:30 | Commemorative Photo & Coffee Break / Visit Exhibits | |
10:30-11:40 | Session IV: Urothelial Cancer II (Advanced disease) | Tag Keun YOO (Korea) |
Moon Ki JO (Korea) | ||
10:30-10:45 | Are genetic testings helpful for treatment decision making in patients with MIBC? | Byeong do SONG (Korea) |
10:45-11:00 | Immuno-oncological agents for metastatic urothelial carcinoma: status quo | Jong Wook KIM (Korea) |
11:00-11:30 | Evidence for the anatomic extent of lymphadenectomy with radical cystectomy | Seth LERNER (USA) |
11:30-11:40 | Case Discussion: Management of complete clinical response following neoadjuvant systemic therapy for MIBC |
Moderator: Jong Kil NAM (Korea) |
Wansuk KIM (Korea) | ||
Yun Beom KIM (Korea) | ||
Hung-Jen Wang (Taiwan) | ||
11:40-12:40 | Luncheon Symposium sponsored by Astellas | Sung Kyu HONG (Korea) |
11:40-12:00 | The Role of Harnal D as an Initial Treatment for LUTS/BPH | Hee Jo YANG (Korea) |
12:00-12:40 | Lunch | |
12:40-13:50 | Session V: Prostate Cancer III (Management of BCR) | Kyung Seop LEE (Korea) |
Lukman HAKIM (Indonesia) | ||
12:40-12:55 | How do we identify patients with BCR who are eligible to delay salvage treatment? | Byung Hoon KIM (Korea) |
12:55-13:10 | Difficulties in the interpretations of PSMA PET imaging | Yoo Sung SONG (Korea) |
13:10-13:25 | Can ARPi treatment bring changes in the management of BCR? | Dongho SHIN (Korea) |
13:25-13:40 | Optimal strategy for BCR after radical prostatectomy | Yong Hyun PARK (Korea) |
13:40-13:50 | Case Discussion: High-risk BCR after radical prostatectomy. What to do? |
Moderator: Kyo Chul Koo (Korea) |
Hyun Chul CHUNG (Korea) | ||
Jae Seung CHUNG (Korea) | ||
Jin Sung PARK (Korea) | ||
Gyoohwan JUNG (Korea) | ||
13:50-14:10 | Satellite Symposium sponsored by Novartis | Sung Kyu HONG (Korea) |
Current insights on Lutetium-177-PSMA-617 radioligand therapy (PLUVICTO) for metastatic castration-resistant prostate cancer | Jae Young JOUNG (Korea) | |
14:10-14:30 | Coffee Break / Visit Exhibits | |
14:30-15:40 | Session VI: Prostate Cancer IV (mCSPC) | Jun Hyuk HONG (Korea) |
Taek Won KANG (Korea) | ||
14:30-14:45 | Sequencing of therapies following treatment intensification for mCSPC | See Min CHOI (Korea) |
14:45-15:00 | Updates on metastasis directed therapy (MDT) for oligometastatic disease | Bum Sik TAE (Korea) |
15:00-15:30 | Personalizing therapy in mHSPC | Deaglan McHugh (USA) |
15:30-15:40 | Case discussion: mCSPC |
Moderator: Seong Hyeon YU (Korea) |
Tae Hyo KIM (Korea) | ||
Seyun KWON (Korea) | ||
Jeong Woo LEE (Korea) | ||
15:40-15:50 | Best Abstract Prize | |
15:50-15:55 | Closing Remarks | Sung Kyu HONG (President, KPS) |
17:00 | Banquet |
Copyright(C) by 2024 KPS in conjunction with APSU Joint International Symposium.
All rights reserved.
Secretariat of KPS
Gaon Convention Services, Inc.
ADDRESS: Room 1005, 228, Gonghang-daero, Gangseo-gu, Seoul, Republic of Korea.
TEL : +82-2-6956-7989 | E-MAIL : gaonpco@gaonpco.com
* 의사 회원인 경우에는 연수평점 카드 기록을 위해서 필요 합니다.